| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Obesity: Original Article |
Endocrine Unit, Division of Endocrinology, Diabetes and Nutrition, Department of Internal Medicine (C.E.J.-A., E.S., A.P., C.A.M.); Hans Wilsdorf Laboratory, Division of Immunology and Allergy, Department of Internal Medicine (R.C., D.B., J.-M.D.); and Plastic Reconstructive Surgery Unit, Division of Reconstructive Surgery, Department of Surgery (B.C.-P.), University Hospital, CH-1211 Geneva 14, Switzerland; La Tour Hospital (P.Q.), CH-1217 Meyrin, Switzerland; and Division of Endocrinology, Diabetology and Metabolism, Department of Medicine (V.G.), University Hospital, CH-1011 Lausanne, Switzerland
Address all correspondence and requests for reprints to: Dr. Christoph A. Meier, Endocrine Unit, University Hospital Geneva, 24, rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: Christoph.Meier{at}medecine.unige.ch.
Adipose tissue is the source of production and site of action of several pro- and antiinflammatory cytokines. We have recently shown that white adipose tissue (WAT) is a major producer of the antiinflammatory IL-1 receptor antagonist (IL-1Ra). Because IL-1Ra serum levels are elevated 7-fold in human obesity and an excess of this protein has been implicated in the acquired resistance to leptin and insulin, we investigated the regulation of IL-1Ra in human WAT.
We demonstrate that IL-1Ra is mainly produced by adipocytes, rather than the stromal fraction of WAT, and that IL-1
and ß, as well as interferon-ß (IFN-ß), strongly up-regulate the expression and secretion of IL-1Ra in WAT. Moreover, human WAT expresses the receptors and proteins known to be required for the action of IL-1 (IL-1 receptor type I, IL-1 receptor accessory protein) and IFN-ß (IFN-
/ß receptor subunits 1 and 2). Finally, human WAT actively secretes these regulatory cytokines, suggesting that they up-regulate IL-1Ra through a local autocrine/paracrine action, which is hypothesized to play a regulatory role in adipogenesis and metabolism.
This work was supported by the Swiss National Science Foundation Grants 3200-064078 0.01 (to C.A.M.) and 32-68286.02 (to J.-M.D.), as well as by a grant from the Hans Wilsdorf Foundation (to D.B. and C.A.M.).
C.E.J.-A. and E.S. contributed equally to this work.
Abbreviations: BMI, Body mass index; FBS, fetal bovine serum; IFN, interferon; IFNAR1 and IFNAR2, IFN-
and -ß receptor subunit 1 and 2; IL-1Ra, IL-1 receptor antagonist; IL-1RAcP, IL-1 receptor-associated protein; IL-1RI and II, IL-1 receptor type I and II; LPS, lipopolysaccharide; PMA, phorbol myristate acetate; WAT, white adipose tissue.
This article has been cited by other articles:
![]() |
G. J. Hausman, C. R. Barb, and R. G. Dean Patterns of gene expression in pig adipose tissue: Transforming growth factors, interferons, interleukins, and apolipoproteins J Anim Sci, October 1, 2007; 85(10): 2445 - 2456. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Maury, K. Ehala-Aleksejev, Y. Guiot, R. Detry, A. Vandenhooft, and S. M. Brichard Adipokines oversecreted by omental adipose tissue in human obesity Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E656 - E665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Ortiz, M. DuTreil, C. Fattman, A. C. Pandey, G. Torres, K. Go, and D. G. Phinney Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury PNAS, June 26, 2007; 104(26): 11002 - 11007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jager, T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J.-F. Tanti Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression Endocrinology, January 1, 2007; 148(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Strandberg, M. Lorentzon, A. Hellqvist, S. Nilsson, V. Wallenius, C. Ohlsson, and J.-O. Jansson Interleukin-1 System Gene Polymorphisms Are Associated with Fat Mass in Young Men J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2749 - 2754. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Somm, E. Henrichot, A. Pernin, C. E. Juge-Aubry, P. Muzzin, J.-M. Dayer, M. J.H. Nicklin, and C. A. Meier Decreased Fat Mass in Interleukin-1 Receptor Antagonist-Deficient Mice: Impact on Adipogenesis, Food Intake, and Energy Expenditure Diabetes, December 1, 2005; 54(12): 3503 - 3509. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Menghini, V. Marchetti, M. Cardellini, M. L. Hribal, A. Mauriello, D. Lauro, P. Sbraccia, R. Lauro, and M. Federici Phosphorylation of GATA2 by Akt Increases Adipose Tissue Differentiation and Reduces Adipose Tissue-Related Inflammation: A Novel Pathway Linking Obesity to Atherosclerosis Circulation, April 19, 2005; 111(15): 1946 - 1953. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |